Tech Company Financing Transactions
Clarus Therapeutics Funding Round
Clarus Therapeutics, based in Northbrook, secured $8 million from H.I.G. Capital, Thomas and McNerny & Partners.
Transaction Overview
Company Name
Announced On
11/27/2007
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series C
Investors
H.I.G. Capital (Lead Investor) (Bruce Robertson)
Thomas, McNerny & Partners (Alexander Zisson)
Proceeds Purpose
Clarus will use the proceeds to support Phase II development of OriTex�, its proprietary oral testosterone product being developed for use in men with low testosterone levels.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Skokie Blvd. 340
Northbrook, IL 60062
USA
Northbrook, IL 60062
USA
Phone
Website
Email Address
Overview
Clarus Therapeutics is an emerging men s health specialty pharmaceutical company preparing for the commercial launch of REXTORO, our oral testosterone (T) replacement therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Dudley
Chief Financial Officer
Steven Bourne
Chief Medical Officer
Theodore Danoff
Browse more venture capital transactions:
Prev: 11/27/2007: Star RF venture capital transaction
Next: 11/27/2007: Snooth venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs